慢性血栓栓塞性肺动脉高压诊疗进展  

Diagnostic and therapeutic progress of chronic thromboembolic pulmonary hypertension

作　　者：高玉婷[1] 王菲[1] 胡威[1] 蔡晓庆[1] 

机构地区：[1]兰州军区兰州总医院心血管内科,甘肃兰州730050

出　　处：《心脏杂志》2017年第3期365-368,共4页Chinese Heart Journal

基　　金：军队保健专项课题资助项目(14BJZ25)

摘　　要：慢性血栓栓塞性肺动脉高压(chronic thromboembolic pulmonary hypertension,CTEPH)由肺动脉血栓栓塞后不完全再通和血管重构而形成,在未接受治疗情况下中位生存期仅不到3年,预后差且极易漏诊或误诊。本文就CTEPH的最新诊疗进展作以综述。Chronic thromboembolic pulmonary hypertension （CTEPH） results from incomplete recanali- zation and remodeling of pulmonary artery after pulmonary thromboembolism. CTEPH patients are often misdiagnosed and have a mean life expectancy of 〈 3 years if untreated. This article reviews the latest clinical progress in diagnosis and treatment of CTEPH.

关 键 词：慢性血栓栓塞性肺动脉高压 肺动脉血栓栓塞 肺动脉内膜剥脱术 肺动脉球囊扩张术 

分 类 号：R543.2[医药卫生—心血管疾病]